Skip to content

13F-HR filed by SILVERARC CAPITAL MANAGEMENT, LLC

SILVERARC CAPITAL MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2024-06-30, filed 2024-08-14, with 70 holding rows worth $423,865,875.

Accession
0001420506-24-001528
Filed
2024-08-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q2 2024

A holdings report, 70 entries on the cover page, a total value of $423,865,875 stated on the cover page (in dollars after the unit check, H1), rows summing to $423,865,875 with VALUE read as dollars as filed, 13F file number 028-21010. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • included managerSilverArc Capital, LLC 028-20993

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
MERUS N VN5749R100COM623,628$36,900,069dollars as filed
NUVALENT INC COM670703107Stock465,710$35,328,761dollars as filed
AVIDITY BIOSCIENCES INC COM05370A108Stock517,734$21,149,434dollars as filed
UROGEN PHARMA LTDM96088105COMMON STOCK1,102,000$18,491,560dollars as filed
ERASCA INC COM29479A108Stock7,816,926$18,447,945dollars as filed
INSMED INC457669907CALL250,000$16,750,000dollars as filedcall
MORPHIC HLDG INC61775R105COM486,306$16,568,445dollars as filed
AKERO THERAPEUTICS INC00973Y108COM625,087$14,664,541dollars as filed
CELLDEX THERAPEUTICS INC NEW15117B202COM NEW374,910$13,875,419dollars as filed
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK192,345$13,173,709dollars as filed
POSEIDA THERAPEUTICS INC73730P108COM3,607,999$10,535,357dollars as filed
COGENT BIOSCIENCES INC19240Q201COM1,206,214$10,168,384dollars as filed
INSMED INC COM PAR $.01457669307Stock140,000$9,380,000dollars as filed
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock36,000$8,748,000dollars as filed
ELUTIA INC05479K106CL A COM1,603,580$7,953,757dollars as filed
CORBUS PHARMACEUTICALS21833P301COM NEW172,492$7,805,263dollars as filed
ORIC PHARMACEUTICALS INC68622P109COM1,075,812$7,605,991dollars as filed
SYNDAX PHARMACEUTICALS INC87164F105COM370,000$7,596,100dollars as filed
RHYTHM PHARMACEUTICALS INC76243J105COM184,662$7,582,222dollars as filed
C4 THERAPEUTICS INC12529R107COM STK1,442,841$6,665,925dollars as filed
SAREPTA THERAPEUTICS INC803607100COM42,000$6,636,000dollars as filed
KALVISTA PHARMACEUTICALS INC483497103COM560,883$6,607,202dollars as filed
VERACYTE INC COM92337F107Stock282,248$6,116,314dollars as filed
ABIVAX SA-00370M103SPONSORED ADS455,800$6,025,676dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM546,863$5,917,058dollars as filed
ADC THERAPEUTICS SAH0036K147COMMON STOCK1,768,770$5,589,313dollars as filed
HELIX ACQUISITION CORP IIG4444H101CL A ORD SHS500,000$5,110,000dollars as filed
Mersana Therapeutics Inc59045L106Common Stock2,500,585$5,026,176dollars as filed
GOSSAMER BIO INC COM38341P102Stock5,500,000$4,954,950dollars as filed
TELA BIO INC872381108COM1,000,000$4,700,000dollars as filed
DISC MEDICINE INC COM254604101Stock101,187$4,560,498dollars as filed
BIOGEN INC COM09062X103Stock19,365$4,489,194dollars as filed
VERONA PHARMA PLC925050106SPONSORED ADS304,633$4,404,993dollars as filed
GERON CORP374163103COM999,270$4,236,905dollars as filed
BIOHAVEN LTDG1110E107COM100,000$3,471,000dollars as filed
LONGBOARD PHARMACEUTICALS IN54300N103COM122,849$3,320,608dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW67,296$2,783,363dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY70,516$2,769,163dollars as filed
BIODESIX INC09075X108COM1,808,959$2,767,707dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM79,194$2,707,643dollars as filed
SOLID BIOSCIENCES INC83422E204COMMON STOCK472,995$2,681,882dollars as filed
PERSPECTIVE THERAPEUTICS INC46489V302COMMON STOCK260,009$2,592,290dollars as filed
CERUS CORP157085101COM1,465,744$2,579,709dollars as filed
COMPUGEN LTDM25722105ORD1,501,113$2,521,870dollars as filed
TREVI THERAPEUTICS INC COM89532M101Stock844,235$2,515,820dollars as filed
KODIAK SCIENCES INC50015M109COM1,062,062$2,495,846dollars as filed
JASPER THERAPEUTICS INC471871202COM NEW109,892$2,494,548dollars as filed
ENGENE HOLDINGS INC29286M105COM263,841$2,488,021dollars as filed
WAVE LIFE SCIENCES LTD SHSY95308105Stock495,471$2,472,400dollars as filed
FULCRUM THERAPEUTICS INC359616109COMMON STOCK398,436$2,470,303dollars as filed
EVOGENE LTDM4119S104SHS3,079,739$2,003,062dollars as filed
STOKE THERAPEUTICS INC86150R107COM141,518$1,911,908dollars as filed
MACROGENICS INC556099109COM370,000$1,572,500dollars as filed
MODULAR MED INC60785L207COM NEW900,000$1,422,000dollars as filed
ZURA BIO LTDG9TY5A101COMMON STOCK328,504$1,149,764dollars as filed
TARSUS PHARMACEUTICALS INC87650L103COMMON STOCK40,000$1,087,200dollars as filed
ALX ONCOLOGY HLDGS INC00166B955PUT167,900$1,012,437dollars as filedput
VYNE THERAPEUTICS INC92941V308COM467,397$920,772dollars as filed
EYEPOINT INC COM NEW30233G209Stock100,000$870,000dollars as filed
89BIO INC282559103COM92,298$739,307dollars as filed
MOLECULAR TEMPLATES INC608550208COM623,838$717,414dollars as filed
FRACTYL HEALTH INC35168W103COM166,666$711,664dollars as filed
C4 THERAPEUTICS INC12529R907CALL150,000$693,000dollars as filedcall
SOLENO THERAPEUTICS INC834203309COM15,000$612,000dollars as filed
KARYOPHARM THERAPEUTICS INC48576U106COM558,466$484,525dollars as filed
MERSANA THERAPEUTICS INC59045L906COM168,300$338,283dollars as filedcall
RELMADA THERAPEUTICS INC75955J402COMMON STOCK99,379$298,137dollars as filed
ALIGOS THERAPEUTICS INC COM NEW01626L105Stock655,515$229,430dollars as filed
VAXCYTE INC COM92243G108Stock2,500$188,775dollars as filed
Rocket Pharmaceuticals Inc W Exp 09/02/20277313F114Warrant104,828$6,363dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-24-001528this filing2024-08-14acceptance time not in the bulk data set